Gene-Edited Beagles Target Dog Allergies in Early Development

Biotech startup Kindred Companion Sciences has created hypoallergenic beagles using CRISPR gene editing, aiming to help millions with dog allergies who cannot tolerate pets.

Kindred Companion Sciences, a New York-based biotech startup, used CRISPR gene editing to develop beagles engineered to not produce the protein triggering dog allergies. This work occurred 2.5 years after similar hypoallergenic cats were first announced by scientists. However, those cats remain unavailable to the public, and experts state additional time and data are required to confirm the hypoallergenic claims for beagles. The timeline from lab development to public availability remains unverified by the source. If successful, this could eventually expand pet access for allergy sufferers, reducing reliance on costly avoidance measures. Currently, the technology is in development and not yet available to the public.

Source: HumanProgress